Recent MSK Discoveries & Advances

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our blog, On Cancer.

and/or

189 News Items found

Feature

Microorganisms in the Gut Can Affect Cancer Outcomes

Discover how microbiome research is revealing the role that bacteria play in cancer treatment.

rod-shaped bacteria

Snapshot

New Cancer Imaging Approach Could Enable Better Detection of Pancreatic Tumors

A new radiopharmaceutical for detecting pancreatic cancer is being evaluated in the first-ever clinical trial of this new drug.

Three images of pancreas tumor

In the Clinic

How Research Is Driving the Latest Treatments for Sarcoma

Surgeon and researcher Aimee Crago discusses the latest treatments for different types of soft tissue sarcoma, including liposarcoma and desmoid tumors.

MSK Surgeon Aimee Crago

In the Lab

Hacking Metastasis: Nanotechnology Researchers Find New Way to Target Tumors

A protein in blood vessels that plays a role in cancer metastasis is a promising target for delivering cancer drugs to tumors using nanoparticles.

Metastatic tumor in the lung, with different colors used to represent the cell nuclei, the blood vessels, and the P-selectin protein.

In the Clinic

Study Suggests Men with Metastatic Prostate Cancer Should Be Tested for Inherited Mutations

Learn why a new finding suggests that men with advanced prostate cancer should be screened for gene mutations.

A doctor speaks with a patient who has advanced prostate cancer about inherited mutations.

In the Clinic

New Targeted Drug Therapy for Advanced Sarcoma Extends Survival by Nearly a Year

Learn more about olaratumab, promising drug that has been shown to extend survival for people with advanced soft tissue sarcoma by nearly a year in a phase II clinical trial.

MSK physician Aimee Crago consults with two colleagues.

Feature

The Future of Cancer Research: Five Reasons for Optimism

Discover some of the most exciting research that Memorial Sloan Kettering scientists are pursuing in the fight against cancer.

DNA molecules wrapped around histones

In the Lab

Surprising Discovery Connects Rare Vascular Disease to Cancer Gene

Researchers found that a common cancer gene called PIK3CA also causes the condition venous malformation. Their discovery has already pointed the way to targeted therapies for this rare and painful condition that affects one in 10,000 people.

scan of mouse blood vessel

In the Lab

New Lung Cancer Therapy May Target Previously Untreatable Tumors

Researchers are developing uses for a drug that could benefit many people with lung cancer.

Colored x-ray of lung cancer

In the Lab

Rapid Results: MSK Researchers Link Genetic Mutation to Rare Bladder Cancer

MSK researchers have identified a genetic mutation that plays a central role in a rare, aggressive form of bladder cancer called plasmacytoid variant carcinoma.

David Solit